A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

Ibuprofen is a household name – the go-to remedy for everything from headaches to period pain. But recent research suggests ...

Triple-negative breast cancer (TNBC) lacks hormone receptors and HER2 amplification, limiting the effectiveness of targeted therapies and contributing to its aggressive clinical behavior. As aberrant ...

He pauses for a moment, holding everything he has. Behind him are seven years pushing his wife’s wheelchair through cancer and daily life.

A Korea University research team has discovered that pitavastatin, a widely used lipid-lowering drug, can directly inhibit ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

The use of proton pump inhibitors with anti-cancer therapies was associated with worse survival outcomes in patients with breast cancer. Concomitant use of proton pump inhibitors and other everyday ...

Next generation Bria-OTS+ platform demonstrates rapid, potent and durable anti-cancer activity by activating both innate and adaptive immune responses Increased tumor cell cytotoxicity induced by both ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...

Scientists have discovered that bacteria living inside tumors can produce a molecule that fights cancer and enhances chemotherapy. The molecule, called 2-methylisocitrate (2-MiCit), was found to make ...